Literature DB >> 9254851

Angiotensinogen and angiotensin-I converting enzyme gene polymorphisms and the risk of coronary artery disease in Chinese.

Y L Ko1, Y S Ko, S M Wang, P H Chu, M S Teng, N J Cheng, W J Chen, T S Hsu, C T Kuo, C W Chiang, Y S Lee.   

Abstract

The homozygous deletion allele (DD) of the angiotensin-I converting enzyme (ACE) gene and the T235 homozygote of the angiotensinogen (AGT) gene have been reported to be correlated with an increased prevalence of coronary artery disease (CAD) and myocardial infarction (MI). The importance of the DD genotype and T235 homozygote as genetic risk factors for CAD in Chinese remains uncertain. This study included 426 patients who underwent coronary angiography and 180 healthy subjects without clinical evidence of CAD. Coronary angiography identified 268 patients with CAD (CAD group) and 158 patients without CAD. The healthy subjects and patients without angiographic evidence of CAD constituted the control group. Three polymorphisms were studied: an insertion/deletion (I/D) polymorphism of the ACE gene and the T174 M and M235T polymorphisms of the AGT gene. No association was found between any of the three studied polymorphisms and the risk of CAD or MI in Chinese using univariate or multivariate analysis. In multivariate analysis, the relative risks were 1.20 (95% confidence interval = 0.91-1.61, P = 0.20) for the DD genotype, 1.05 (95% CI = 0.82-1.35, P = 0.69) for the T174 homozygote, and 1.19 (95% CI = 0.91-1.55, P = 0.20) for the T235 homozygote. Similarly, no significant difference was found in the frequencies of the DD genotype and the T174 and T235 homozygotes between the control group, the CAD group, the non-MI group, and the MI group when analyzed according to sex, age, or degree of risk. Our data suggest that neither the DD genotype of the ACE I/D polymorphism nor the T174 and T235 homozygotes of the AGT gene confer significant risk for CAD or MI in Chinese.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9254851     DOI: 10.1007/s004390050492

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  6 in total

1.  Impact of renin-angiotensin-aldosterone system polymorphisms on myocardial perfusion: Correlations with myocardial single photon emission computed tomography-derived parameters.

Authors:  George Angelidis; Maria Samara; Maria Papathanassiou; Maria Satra; Varvara Valotassiou; Ioannis Tsougos; Dimitrios Psimadas; Chara Tzavara; Sotiria Alexiou; John Koutsikos; Nikolaos Demakopoulos; Gregory Giamouzis; Filippos Triposkiadis; John Skoularigis; Panagoula Kollia; Panagiotis Georgoulias
Journal:  J Nucl Cardiol       Date:  2018-01-17       Impact factor: 5.952

2.  The M235T polymorphism in the AGT gene and CHD risk: evidence of a Hardy-Weinberg equilibrium violation and publication bias in a meta-analysis.

Authors:  Mohammad Hadi Zafarmand; Yvonne T van der Schouw; Diederick E Grobbee; Peter W de Leeuw; Michiel L Bots
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

3.  Angiotensinogen-M235T as a risk factor for myocardial infarction in Asian populations: a genetic association study and a bioinformatics approach.

Authors:  Fariba Raygan; Mohammad Karimian; Atefeh Rezaeian; Bahareh Bahmani; Mohaddeseh Behjati
Journal:  Croat Med J       Date:  2016-08-31       Impact factor: 1.351

4.  Gene polymorphism associated with angiotensinogen (M235T), endothelial lipase (584C/T) and susceptibility to coronary artery disease: a meta-analysis.

Authors:  Hongyan Zhao; Ranzun Zhao; Shan Hu; Jidong Rong
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

5.  The effect of polymorphisms (M235T and T174M) on the angiotensinogen gene (AGT) in coronary artery disease in the Eastern Asian population: A systematic review and meta-analysis.

Authors:  Qian Zhang; Qingning Huang; Xianen Wang; Yong Wang; Xiaofang Hua
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

6.  Association between T174M polymorphism in the angiotensinogen gene and risk of coronary artery disease: a meta-analysis.

Authors:  Wen-Zhu Wang
Journal:  J Geriatr Cardiol       Date:  2013-03       Impact factor: 3.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.